Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the "New-Drug Re-examination"

NCT02578238 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02578238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02578238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance of Humira in Korean Pediatric CD Patients Under the "New-Drug Re-examination"
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
September 24, 2015
Completion date
May 31, 2017
Enrollment
143 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric crohn's disease